Clinical Trials Browser

Phase 2 × Unresectable Locally Recurrent Rectal Cancer × Drug Therapy × Clear all

NCT06767007 2025-01-22

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

Phase 2 Recruiting

Gastrointestinal

Unresectable Locally Recurrent Rectal Cancer